Recon: EC authorizes Eisai, Biogen Alzheimer’s drug for early treatment; CDC advisers begin review of vaccine guidelines
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States